<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>İşte içerik için uygun 5 etiket: **Prostate cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/iste-icerik-icin-uygun-5-etiket-prostate-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Jan 2026 17:33:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>İşte içerik için uygun 5 etiket: **Prostate cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Enhancers Control Androgen Receptor in Prostate Cancer</title>
		<link>https://bioengineer.org/enhancers-control-androgen-receptor-in-prostate-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 18 Jan 2026 17:33:44 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[AR downstream enhancer]]></category>
		<category><![CDATA[Chromatin looping]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **Prostate cancer]]></category>
		<category><![CDATA[Treatment resistance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/enhancers-control-androgen-receptor-in-prostate-cancer/</guid>

					<description><![CDATA[A significant breakthrough in understanding prostate cancer has emerged from recent research highlighting the role of an enhancer element located 65 kb downstream of the androgen receptor (AR) gene. This enhancer, denoted as the AR downstream enhancer, has been observed to undergo amplification in castration-resistant prostate cancer (CRPC) samples following treatment with androgen receptor pathway [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317994</post-id>	</item>
	</channel>
</rss>
